Please Wait.....
Report
Post Traumatic Stress Disorder (PTSD) Market Report and Forecast 2024-2032
Market Report (7 days) I 2024-02-13 I 180 Pages I EMR Inc.
Post Traumatic Stress Disorder (PTSD) Market Report and Forecast 2024-2032
Post Traumatic Stress Disorder (PTSD) Market Outlook
The post-traumatic stress disorder (PTSD) market size is expected to grow at a CAGR of 5.4% during the forecast period of 2024-2032 in the major markets, driven by increasing prevalence of post-traumatic stress disorder (PTSD), along with reducing stigma around mental health conditions.
Post Traumatic Stress Disorder (PTSD): Introduction
Post Traumatic Stress Disorder (PTSD) is a mental health condition triggered by experiencing or witnessing a terrifying event. Symptoms include flashbacks, nightmares, severe anxiety, and uncontrollable thoughts about the event. Individuals may also experience emotional numbness and avoidance of situations that remind them of the trauma. PTSD can impair daily functioning and relationships. Treatment often involves psychotherapy, medication, or a combination, aiming to improve symptoms, teach coping strategies, and restore normal functioning.
Key Trends in the Post Traumatic Stress Disorder (PTSD) Market
There's a growing recognition of PTSD beyond traditional contexts like military veterans, encompassing first responders, victims of abuse, and survivors of accidents or natural disasters. This broader understanding is leading to increased diagnosis rates and a higher demand for treatment services.
The market is seeing a shift towards integrated treatment models that combine psychotherapy, medication, and holistic approaches like mindfulness, yoga, and acupuncture. Personalized treatment plans are becoming more common, addressing the individual needs of patients.
Telehealth services, mobile apps, and online therapy platforms are becoming increasingly popular for providing accessible PTSD treatment, especially in remote or underserved areas. Digital platforms also facilitate continuous monitoring and support for individuals with PTSD.
There's a growing emphasis on early intervention and preventive measures in high-risk populations. Programs aimed at education, resilience training, and early trauma counselling are being implemented in various settings, from schools to the military.
The pharmaceutical aspect of the PTSD market is exploring beyond traditional antidepressants. Research into new drug classes and the potential therapeutic use of substances like MDMA and psilocybin for treatment-resistant PTSD is gaining attention.
Increased government funding and supportive regulations for mental health services, including PTSD treatment, are promoting the growth of the market. There's also a trend towards policies that ensure better coverage and access to PTSD therapies under health insurance.
Post Traumatic Stress Disorder Market Segmentation
Market Breakup by Treatment Type
- Drug Administration
- Psychotherapy
Market Breakup by Drug Class
- Antidepressants
- Anti-Anxiety Drugs
- Antipsychotic Drugs
- Others
Market Breakup by Patient Type
- Children
- Adult
Market Breakup by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Other Distribution Channels
Market Breakup by Region
- United States
- EU-4 and the United Kingdom
o Germany
o France
o Italy
o Spain
o United Kingdom
- Japan
Post Traumatic Stress Disorder (PTSD) Market Overview
In North America, the PTSD market is influenced by a high awareness of mental health issues and robust healthcare infrastructure. The region has a significant number of veterans and active military personnel, leading to focused PTSD research and treatment programs. There's also a growing acceptance of mental health services and an increase in the use of therapy, including cognitive-behavioral therapy and EMDR, coupled with pharmaceutical interventions.
Europe's market is characterized by strong mental health policies and a focus on integrated care. The region benefits from universal healthcare systems, ensuring access to mental health services. There's an emphasis on early intervention and community-based support, with countries like the UK and Germany leading in mental health research and therapy services. The market is also influenced by initiatives aimed at reducing the stigma associated with mental health conditions, including PTSD.
The PTSD market in the Japan region is growing, driven by increasing recognition of mental health issues and improving healthcare infrastructure. Cultural factors and stigma associated with mental health can pose challenges. However, there's a gradual shift towards recognizing and treating PTSD, especially in countries with increasing urbanization and changing social dynamics. The market shows potential for growth in therapy services and pharmaceutical treatments, though access to care varies across the region.
Post Traumatic Stress Disorder (PTSD) Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
- Sanofi-aventis Groupe
- Emergent BioSolutions Inc.
- Valneva SE
- GlaxoSmithKline plc.
- Intervet Inc.
- EuBiologics Co., Ltd.
- Astellas Pharma Inc.
- Celldex Therapeutics.
- Johnson & Johnson Services Inc.
- Merck & Co. Inc.
- Marinus Pharmaceuticals, Inc.
- Tonix Pharmaceuticals Holding Corp.
- Greenstone LLC
- Otsuka Pharmaceutical Co., Ltd
- Prometheon Pharma, LLC.
We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Post Traumatic Stress Disorder (PTSD) Epidemiology Analysis - 7MM
3.1 7MM Epidemiology Scenario Overview (2017-2032)
3.2 United States Post Traumatic Stress Disorder (PTSD) Epidemiology Forecast (2017-2032)
3.3 EU-4 and United Kingdom Post Traumatic Stress Disorder (PTSD) Epidemiology Forecast (2017-2032)
3.3.1 Germany Post Traumatic Stress Disorder (PTSD) Epidemiology Forecast (2017-2032)
3.3.2 France Post Traumatic Stress Disorder (PTSD) Epidemiology Forecast (2017-2032)
3.3.3 Italy Post Traumatic Stress Disorder (PTSD) Epidemiology Forecast (2017-2032)
3.3.4 Spain Post Traumatic Stress Disorder (PTSD) Epidemiology Forecast (2017-2032)
3.3.5 United Kingdom Post Traumatic Stress Disorder (PTSD) Epidemiology Forecast (2017-2032)
3.4 Japan Post Traumatic Stress Disorder (PTSD) Epidemiology Forecast (2017-2032)
4 Post Traumatic Stress Disorder (PTSD) Market Overview - 7MM
4.1 Post Traumatic Stress Disorder (PTSD) Market Historical Value (2017-2023)
4.2 Post Traumatic Stress Disorder (PTSD) Market Forecast Value (2024-2032))
5 Post Traumatic Stress Disorder (PTSD) Market Landscape-7MM
5.1 Post Traumatic Stress Disorder (PTSD) Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Post Traumatic Stress Disorder (PTSD) Product Landscape
5.2.1 Analysis by Diseases Type
5.2.2 Analysis by Treatments
5.2.3 Analysis by Route of Administration
6 Post Traumatic Stress Disorder (PTSD) Treatment Challenges and Unmet Needs
6.1 Treatment Pathway Challenges
6.2 Compliance and Drop-Out Analysis
6.3 Awareness and Prevention Gaps
7 Cost of Treatment
8 Post Traumatic Stress Disorder (PTSD) Market Dynamics
8.1 Market Drivers and Constraints
8.2 SWOT Analysis
8.3 Porter's Five Forces Model
8.4 Key Demand Indicators
8.5 Key Price Indicators
8.6 Industry Events, Initiatives, and Trends
8.7 Value Chain Analysis
9 Post Traumatic Stress Disorder (PTSD) Market Segmentation -7MM
9.1 Post Traumatic Stress Disorder (PTSD) Market by Treatment Type
9.1.1 Market Overview
9.1.2 Drug Administration
9.1.3 Psychotherapy
9.2 Post Traumatic Stress Disorder (PTSD) Market by Drug Class
9.2.1 Market Overview
9.2.2 Antidepressants
9.2.3 Anti-Anxiety Drugs
9.2.4 Antipsychotic Drugs
9.2.5 Others
9.3 Post Traumatic Stress Disorder (PTSD) Market by Patient Type
9.3.1 Market Overview
9.3.2 Children
9.3.3 Adult
9.4 Post Traumatic Stress Disorder (PTSD) Market by Distribution Channel
9.4.1 Market Overview
9.4.2 Hospital Pharmacies
9.4.3 Retail Pharmacies
9.4.4 Other Distribution Channels
9.5 Post Traumatic Stress Disorder (PTSD) Market by Region
9.5.1 Market Overview
9.5.2 United States
9.5.3 EU-4 and the United Kingdom
9.5.3.1 Germany
9.5.3.2 France
9.5.3.3 Italy
9.5.3.4 Spain
9.5.3.5 United Kingdom
9.5.4 Japan
10 United States Post Traumatic Stress Disorder (PTSD) Market
10.1 Post Traumatic Stress Disorder (PTSD) Market Historical Value (2017-2023)
10.2 Post Traumatic Stress Disorder (PTSD) Market Forecast Value (2024-2032)
10.3 Post Traumatic Stress Disorder (PTSD) Market by Disease Type
10.4 Post Traumatic Stress Disorder (PTSD) Market by Treatment Type
11 EU-4 and United Kingdom Post Traumatic Stress Disorder (PTSD) Market
11.1 Post Traumatic Stress Disorder (PTSD) Market Historical Value (2017-2023)
11.2 Post Traumatic Stress Disorder (PTSD) Market Forecast Value (2024-2032)
11.3 Germany Post Traumatic Stress Disorder (PTSD) Market Overview
11.3.1 Post Traumatic Stress Disorder (PTSD) Market by Disease Type
11.3.2 Post Traumatic Stress Disorder (PTSD) Market by Treatment Type
11.4 France Post Traumatic Stress Disorder (PTSD) Market Overview
11.4.1 Post Traumatic Stress Disorder (PTSD) Market by Disease Type
11.4.2 Post Traumatic Stress Disorder (PTSD) Market by Treatment Type
11.5 Italy Post Traumatic Stress Disorder (PTSD) Market Overview
11.5.1 Post Traumatic Stress Disorder (PTSD) Market by Disease Type
11.5.2 Post Traumatic Stress Disorder (PTSD) Market by Treatment Type
11.6 Spain Post Traumatic Stress Disorder (PTSD) Market Overview
11.6.1 Post Traumatic Stress Disorder (PTSD) Market by Disease Type
11.6.2 Post Traumatic Stress Disorder (PTSD) Market by Treatment Type
11.7 United Kingdom Post Traumatic Stress Disorder (PTSD) Market Overview
11.7.1 Post Traumatic Stress Disorder (PTSD) Market by Disease Type
11.7.2 Post Traumatic Stress Disorder (PTSD) Market by Treatment Type
12 Japan Post Traumatic Stress Disorder (PTSD) Market
12.1 Post Traumatic Stress Disorder (PTSD) Market Historical Value (2017-2023)
12.2 Post Traumatic Stress Disorder (PTSD) Market Forecast Value (2024-2032)
12.2.1 Post Traumatic Stress Disorder (PTSD) Market by Disease Type
12.2.2 Post Traumatic Stress Disorder (PTSD) Market by Treatment Type
13 Regulatory Framework
13.1 Regulatory Overview
13.2 US FDA
13.3 EU EMA
13.4 INDIA CDSCO
13.5 JAPAN PMDA
13.6 Others
14 Patent Analysis
14.1 Analysis by Type of Patent
14.2 Analysis by Publication year
14.3 Analysis by Issuing Authority
14.4 Analysis by Patent Age
14.5 Analysis by CPC Analysis
14.6 Analysis by Patent Valuation
14.7 Analysis by Key Players
15 Grants Analysis
15.1 Analysis by year
15.2 Analysis by Amount Awarded
15.3 Analysis by Issuing Authority
15.4 Analysis by Grant Application
15.5 Analysis by Funding Institute
15.6 Analysis by NIH Departments
15.7 Analysis by Recipient Organization
16 Clinical Trials Analysis
16.1 Analysis by Trial Registration Year
16.2 Analysis by Trial Status
16.3 Analysis by Trial Phase
16.4 Analysis by Therapeutic Area
16.5 Analysis by Geography
17 Funding and Investment Analysis
17.1 Analysis by Funding Instances
17.2 Analysis by Type of Funding
17.3 Analysis by Funding Amount
17.4 Analysis by Leading Players
17.5 Analysis by Leading Investors
17.6 Analysis by Geography
18 Partnership and Collaborations Analysis
18.1 Analysis by Partnership Instances
18.2 Analysis by Type of Partnership
18.3 Analysis by Leading Players
18.4 Analysis by Geography
19 Supplier Landscape
19.1 Sanofi-aventis Groupe
19.1.1 Financial Analysis
19.1.2 Product Portfolio
19.1.3 Demographic Reach and Achievements
19.1.4 Mergers and Acquisitions
19.1.5 Certifications
19.2 Emergent BioSolutions Inc.
19.2.1 Financial Analysis
19.2.2 Product Portfolio
19.2.3 Demographic Reach and Achievements
19.2.4 Mergers and Acquisitions
19.2.5 Certifications
19.3 Valneva SE
19.3.1 Financial Analysis
19.3.2 Product Portfolio
19.3.3 Demographic Reach and Achievements
19.3.4 Mergers and Acquisitions
19.3.5 Certifications
19.4 GlaxoSmithKline plc.
19.4.1 Financial Analysis
19.4.2 Product Portfolio
19.4.3 Demographic Reach and Achievements
19.4.4 Mergers and Acquisitions
19.4.5 Certifications
19.5 Intervet Inc.
19.5.1 Financial Analysis
19.5.2 Product Portfolio
19.5.3 Demographic Reach and Achievements
19.5.4 Mergers and Acquisitions
19.5.5 Certifications
19.6 EuBiologics Co., Ltd.
19.6.1 Financial Analysis
19.6.2 Product Portfolio
19.6.3 Demographic Reach and Achievements
19.6.4 Mergers and Acquisitions
19.6.5 Certifications
19.7 Astellas Pharma Inc.
19.7.1 Financial Analysis
19.7.2 Product Portfolio
19.7.3 Demographic Reach and Achievements
19.7.4 Mergers and Acquisitions
19.7.5 Certifications
19.8 Celldex Therapeutics.
19.8.1 Financial Analysis
19.8.2 Product Portfolio
19.8.3 Demographic Reach and Achievements
19.8.4 Mergers and Acquisitions
19.8.5 Certifications
19.9 Johnson & Johnson Services Inc.
19.9.1 Financial Analysis
19.9.2 Product Portfolio
19.9.3 Demographic Reach and Achievements
19.9.4 Mergers and Acquisitions
19.9.5 Certifications
19.10 Merck & Co. Inc.
19.10.1 Financial Analysis
19.10.2 Product Portfolio
19.10.3 Demographic Reach and Achievements
19.10.4 Mergers and Acquisitions
19.10.5 Certifications
19.11 Marinus Pharmaceuticals, Inc.
19.11.1 Financial Analysis
19.11.2 Product Portfolio
19.11.3 Demographic Reach and Achievements
19.11.4 Mergers and Acquisitions
19.11.5 Certifications
19.12 Tonix Pharmaceuticals Holding Corp.
19.12.1 Financial Analysis
19.12.2 Product Portfolio
19.12.3 Demographic Reach and Achievements
19.12.4 Mergers and Acquisitions
19.12.5 Certifications
19.13 Greenstone LLC
19.13.1 Financial Analysis
19.13.2 Product Portfolio
19.13.3 Demographic Reach and Achievements
19.13.4 Mergers and Acquisitions
19.13.5 Certifications
19.14 Otsuka Pharmaceutical Co., Ltd
19.14.1 Financial Analysis
19.14.2 Product Portfolio
19.14.3 Demographic Reach and Achievements
19.14.4 Mergers and Acquisitions
19.14.5 Certifications
19.15 Prometheon Pharma, LLC.
19.15.1 Financial Analysis
19.15.2 Product Portfolio
19.15.3 Demographic Reach and Achievements
19.15.4 Mergers and Acquisitions
19.15.5 Certifications
20 Post Traumatic Stress Disorder (PTSD) - Distribution Model (Additional Insight)
20.1 Overview
20.2 Potential Distributors
20.3 Key Parameters for Distribution Partner Assessment
21 Key Opinion Leaders (KOL) Insights (Additional Insight)
22 Company Competitiveness Analysis (Additional Insight)
22.1 Very Small Companies
22.2 Small Companies
22.3 Mid-Sized Companies
22.4 Large Companies
22.5 Very Large Companies
23 Payment Methods (Additional Insight)
23.1 Government Funded
23.2 Private Insurance
23.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security